Cost-effectiveness analysis of patent foramen ovale closure with Amplatzer plus medical therapy compared to medical therapy in patients with a history of stroke in France.
Fiche publication
Date publication
novembre 2021
Journal
Journal of cardiology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr LORGIS Luc
Tous les auteurs :
Allou A, Baschet L, Sabourin C, Montalscot G, Lorgis L, Iriart X
Lien Pubmed
Résumé
A patent foramen ovale (PFO) is formed when the ovale foramen does not close spontaneously or re-opens leaving the right and left atrium connected. The present study was conducted to analyze the cost-effectiveness of PFO closure with Amplatzer device plus medical therapy (MT) compared to MT alone in the French reimbursement system for PFO patients with a prior history of stroke, using the RESPECT study data.
Mots clés
Cost-effectiveness analysis, Patent foramen ovale, Patent foramen ovale closure, Quality-adjusted life year, Stroke
Référence
J Cardiol. 2021 Nov 10;: